High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$1.2M
$1,204,668
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
|
AMLX
S
Amylyx Pharmaceuticals, Inc.
Bedrosian Camille L
• Officer • Chief Medical Officer
Sell to Cover
2026-03-02
$94,205
|
||||||
| AMLX |
Amylyx Pharmaceuticals, Inc.
|
Officer • Chief Medical Officer
Sell to Cover
|
2026-03-02 | $94,205 | S | Form 4 |
| AMLX |
Amylyx Pharmaceuticals, Inc.
|
CEO
Sell to Cover
|
2026-03-02 | $424,120 | S | Form 4 |
| AMLX |
Amylyx Pharmaceuticals, Inc.
|
CFO
Sell to Cover
|
2026-03-02 | $114,851 | S | Form 4 |
| AMLX |
Amylyx Pharmaceuticals, Inc.
|
CEO
Sell to Cover
|
2026-03-02 | $423,760 | S | Form 4 |
|
AMLX
S
Amylyx Pharmaceuticals, Inc.
Mazzariello Gina
• Officer • Chief Legal Officer
Sell to Cover
2026-03-02
$99,378
|
||||||
| AMLX |
Amylyx Pharmaceuticals, Inc.
|
Officer • Chief Legal Officer
Sell to Cover
|
2026-03-02 | $99,378 | S | Form 4 |
|
AMLX
S
Amylyx Pharmaceuticals, Inc.
Mazzariello Gina
• Officer • Chief Legal Officer
Sell to Cover
2026-02-23
$48,352
|
||||||
| AMLX |
Amylyx Pharmaceuticals, Inc.
|
Officer • Chief Legal Officer
Sell to Cover
|
2026-02-23 | $48,352 | S | Form 4 |